177 Lu-DOTATATE Therapy in a Case of Castrate-Resistant Prostate Cancer With Neuroendocrine Differentiation. Shu Q, Li X, Chen X, Chen Y, et al. Clin Nucl Med 2023;48:e371-e373.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shu Q, Li X, Chen X, Chen Y, et al. 177 Lu-DOTATATE Therapy in a Case of Castrate-Resistant Prostate Cancer With Neuroendocrine Differentiation. Clin Nucl Med 2023;48:e371-e373.
PMID: 37276491